Acute coronary syndrome without ST elevation: implementation of new guidelines.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  The Lancet

• Publication date

  2001-11-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(01)06585-0PMID 11705583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Actualización (2002) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST

  2002cited by this paper
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation

  2001cited by this paper
• [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban].

  2001cited by this paper
• Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.

  2001cited by this paper
• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2001cited by this paper
• Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

  2001cited by this paper
• Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.

  2001cited by this paper
• Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

  2001cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• It's time for a change to a troponin standard.

  2000cited by this paper
• Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

  2000cited by this paper
• Practice guidelines developed by specialty societies: the need for a critical appraisal.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

  2000cited by this paper
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

  2000cited by this paper
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)

  2000cited by this paper
• Improving the quality and dissemination of guidelines: the quest for the Holy Grail.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.

  2000cited by this paper
• A classification of unstable angina revisited.

  2000cited by this paper
• [Legal implications of medical guidelines. A Task Force of the European Society of Cardiology].

  2000cited by this paper
• Guías de práctica clínica de la Sociedad Española de Cardiología en la angina inestable/infarto sin elevación ST

  2000cited by this paper
• Improving the quality and dissemination of guidelines: the quest for the Holy Grail

  2000cited by this paper
• Why don't physicians follow clinical practice guidelines? A framework for improvement.

  1999cited by this paper
• Task Force Report: The legal implications of medical guidelines--a Task Force of the European Society of Cardiology.

  1999cited by this paper
• National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.

  1999cited by this paper
• Clinical guidelines: developing guidelines.

  1999cited by this paper
• Acute coronary syndromes: diagnosis

  1999cited by this paper
• Unstable angina: an etiologic approach to management.

  1998cited by this paper
• Unstable angina: Specialty‐related disparities in implementation of practice guidelines

  1998cited by this paper
• 28th Bethesda Conference. Task Force 2: Guideline implementation.

  1997cited by this paper
• The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol.

  1996cited by this paper
• 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

  1996cited by this paper
• Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

  1996cited by this paper
• Unstable angina : diagnosis and management

  1994cited by this paper

• Clinical Utility of Immature Platelet Fraction (IPF) as a Biomarker in the Diagnosis of Acute Coronary Syndrome (ACS)

  2025cites this paper
• A cross-sectional study determining prevalence and factors associated with ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction in Iran: results from fasa registry on acute myocardial infarction (FaRMI)

  2024cites this paper
• Diagnostic value and prognostic significance of CTRP9 combined with pentraxin-3 in acute coronary syndrome

  2021influential citation
• Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome

  2019cites this paper
• Duration of Dual Antiplatelet Therapy After€Coronary Stenting

  2017cites this paper
• Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios Grupo de Trabajo sobre el uso de agentes antiplaquetarios en pacientes con enfermedad cardiovascular aterosclerótica de la Sociedad Europea de Cardiología

  2016cites this paper
• Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.

  2016cites this paper
• Plasma Pentraxin 3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease

  2016cites this paper
• Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence.

  2016cites this paper
• DIAGNOSIS OF MYOCARDIAL ISCHEMIA USING PLASMA FREE FATTY ACID AS A BIOMARKER

  2015cites this paper
• Medical Treatment of Unstable Angina and Acute Non-ST-Elevation Myocardial Infarction

  2015cites this paper
• Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence.

  2015cites this paper
• Management and decision‐making process leading to coronary angiography and revascularization in octogenarians with coronary artery disease: Insights from a large single‐center registry

  2015cites this paper
• Temporal Data Mining in Electronic Medical Records from Patients with Acute Coronary Syndrome

  2014cites this paper
• Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.

  2014cites this paper
• Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome

  2014cites this paper
• Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.

  2013cites this paper
• 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• Cardiac biomarkers in acute myocardial infarction.

  2013cites this paper
• Exploring Pathophysiology of Acute Coronary Syndrome for Novel Biomarkers

  2013cites this paper
• ACCF/AHA Practice Guideline

  2013cites this paper
• Electrocardiogram in a Man with Chest Pain and Widespread Atherosclerotic Disease

  2012cites this paper
• Multimodality Imaging Evaluation of Functional and Clinical Benefits of Percutaneous Coronary Intervention in Patients with Chronic Total Occlusion Lesion

  2012cites this paper
• Abciximab

  2012cites this paper
• Enoxaparin

  2012cites this paper
• Cardiological Biopharmaceuticals in the Conception of Drug Targeting Delivery: Practical Results and Research Perspectives

  2012cites this paper
• Traditional and Novel Risk Factors in Atherothrombosis

  2012cites this paper
• Marcadores inflamatórios de instabilidade da placa aterosclerótica coronária : caraterização e potencial utilização clínica

  2012cites this paper
• The use of troponin in general practice.

  2012cites this paper
• In search for novel biomarkers of acute coronary syndrome.

  2012cites this paper
• Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic Significance.

  2011cites this paper
• 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Proteómica cardiovascular: análisis proteómico de plasma y monocitos circulantes humanos en pacientes con síndrome coronario agudo

  2011cites this paper
• The evolution of chest pain pathways.

  2011cites this paper
• 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c

  2011cites this paper
• Revaluation of clopidogrel: let the data speak for themselves

  2010cites this paper
• Revaluation of clopidogrel: let the data speak for themselves

  2010cites this paper
• Role of 64-slice cardiac computed tomography in the evaluation of patients with non-ST-elevation acute coronary syndrome

  2010cites this paper
• AS-5: Long-Term Myocardial Functional Improvement after Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with ST-Segment Elevation Myocardial Infarction (STEMI): 4-Years Follow-Up

  2009cites this paper
• Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up

  2009cites this paper
• Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

  2009cites this paper
• Chapter 16 Acute Coronary Syndromes

  2009cites this paper
• Biochemical Cardiac Markers in Clinical Cardiology

  2009cites this paper
• 8 – Moyens Thérapeutiques Actuels et Modernes

  2009cites this paper
• Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit.

  2008cites this paper
• Diagnóstico electrocardiográfico de los síndromes coronarios agudos

  2008cites this paper
• Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit.

  2008cites this paper
• Principales cuidados de enfermería en la persona con cardiopatía isquémica

  2008cites this paper
• Effects of Bulbus allii macrostemi on clinical outcomes and oxidized low‐density lipoprotein and plasminogen in unstable angina/non‐ST‐segment elevation myocardial infarction patients

  2008cites this paper
• Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection.

  2008cites this paper
• Prevalencia de la anatomía coronaria de pacientes sometidos a angioplastia en el servicio de intervencionismo cardiovascular del Hospital Metropolitano de Quito (evolución agosto 2002-julio 2005)

  2008cites this paper
• Putting the future in service of the present: Risk assessment in acute coronary syndrome patients

  2007cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cites this paper
• Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice

  2007cites this paper
• Coronary angiography in the elderly with acute myocardial infarction.

  2007cites this paper
• Medical Treatment of Unstable Angina, Acute Non-ST-Elevation Myocardial Infarction, and Coronary Artery Spasm

  2007cites this paper
• Multislice CT in emergency room management of patients with chest pain and medium-low probability of acute coronary syndrome

  2006cites this paper
• Invasive treatment of coronary artery disease

  2006cites this paper
• Downstream administration of a high-dose tirofiban bolus in high-risk patients with unstable angina undergoing early percutaneous coronary intervention.

  2006cites this paper
• Behandlungspfad „Akutes Koronarsyndrom“

  2006cites this paper
• Laboratory network of excellence: enhancing patient safety and service effectiveness

  2006cites this paper
• [Clinical pathway "Acute Coronary Syndrome"].

  2006cites this paper
• Proper use of glycoprotein IIb/IIIa inhibitors in patients with non-ST elevation acute coronary syndromes undergoing coronary angiography: frankly, my dear, I don't give a damn

  2006cites this paper
• Invasive treatment of coronary artery disease : lessons from clinical trials and clinical practice

  2006cites this paper
• Coronary revascularization for non-ST elevation acute coronary syndrome: state of the art

  2006cites this paper
• Laboratory network of excellence: enhancing patient safety and service effectiveness / Labor-Network of Excellence: bessere Sicherheit für Patienten und effektivere Labordienstleistungen

  2006cites this paper
• Prevention of Cardiovascular Events after Acute Coronary Syndrome

  2005cites this paper
• Coronary Artery Disease in HIV-Infected Patients: Clinical Presentation, Pathophysiology, Prognosis, Prevention, and Treatment

  2005cites this paper
• RENASICA II. Registro Mexicano de Síndromes Coronarios Agudos

  2005cites this paper
• SP Masud, R Mackenzie. Acute Coronary Syndrome.

  2005cites this paper
• Diabetiker und akutes Koronarsyndrom

  2005cites this paper
• Cardiovascular disease in AIDS

  2005cites this paper
• Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up.

  2005cites this paper
• Prepercutaneous coronary intervention plasma homocysteine concentration is a useful predictor of angioplasty-induced myocardial damage.

  2005cites this paper
• Das akute Koronarsyndrom in der Prähospitalphase

  2005cites this paper
• Biomarkers in acute coronary syndromes and their role in diabetic patients

  2005cites this paper
• [Acute coronary syndrome in the prehospital phase].

  2005cites this paper
• Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome.

  2005cites this paper
• Early initiation of statin therapy in acute coronary syndromes: a review of the evidence.

  2005cites this paper
• Sensitive spectrophotometric assay for plasma oxalate.

  2005cites this paper
• RENASICA II Mexican Registry of Acute Coronary Syndromes

  2005cites this paper
• [Management of acute coronary syndromes without ST elevation: the TOSCANE registry].

  2005cites this paper
• The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease.

  2005cites this paper
• Severe spasm of a large patent ductus arteriosus.

  2005influential citation
• Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides

  2004cites this paper
• Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes

  2004cites this paper
• Spectrum of Acute Coronary Syndromes: History and Clinical Presentation in Relation to Sex and Age

  2004cites this paper
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

  2004cites this paper
• Reference values for cardiac troponins I and T in a goal-oriented concept of health: cardiac marker values in a series of outpatients without acute coronary syndromes.

  2004cites this paper
• [Expert consensus document on the use of antiplatelet agents].

  2004cites this paper
• Absence of ST elevation in ECG leads V7, V8, V9 in ischaemia of non-occlusive aetiologies.

  2004cites this paper
• Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome , a report from GUSTO IV-ACS

  2004cites this paper
• Role and importance of biochemical markers in clinical cardiology.

  2004cites this paper
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cites this paper
• Biochemical markers of cardiac diseases

  2004cites this paper
• Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios

  2004cites this paper
• Nuevas estrategias antitrombóticas en la trombosis arterial

  2004cites this paper
• N-Terminal Pro-Brain Natriuretic Peptide Levels in Patients with Non-ST-Elevation Myocardial Infarction

  2004cites this paper